We're in The Longest Uptrend Since The ReverseSplit!
last August, 2014
Look at the weekly chart, if you want to follow along. We've just had 4 weeks of upward action. And the share price is trading above the 20 and 50 moving averages.
So, this is a slight positive.
Remember, we've only been on the NSDQ for 9 weeks !
I look at something like this 4 week run as akin to building a rather large bon fire. For 4 weeks, now 5, the dry wood has been gathered and carefully piled to burn evenly and maintain good air flow when burning.
If we get a positive announcement or something emerges from somewhere, it will be like a spark that sets things ablaze, and the share price will takeoff.
We can also get a down pour, and have to start again.
The reverse split begat the NSDQ which has now lead us to the Funds beginning to buy after only 9 weeks !!!
It's important to put the funds issue into proper perspective, and point out the essential item of importance of the Funds.
The essential item of importance is that the funds have discovered OCAT in the first place.
And secondly, it's good to know, the funds follow each other. When one buys, others buy. So, it's a beginning.
So, an uptrend has begun, now let's see if it lasts!
If the share price blows through the 200 day moving average at 8.35, that'll be a breakout! OCAT hasn't traded above the 200 day, since 2011. (weekly chart)
The latest news from the European EMA, is ALSO positive, VERY POSITIVE.
Sooner or later, the share price will move to reward the good news that continues to flow.
The FDA will probably act before too long. And I expect that will be positive news as well.
Increment, by increment Ocata continues to make progress.
So, this uptrend has no magnitude, it's a 1 point move, but it's still the most sustained move since last August.
And it's interesting because it's AFTER, the NSDQ up list. It's the first emerging technical event after the nasdaq up list. So, we'll see.
We can, ... take the stem cells and turn them into essentially brand new, young, juvenile retinal pigment epithelium and give somebody a fresh layer of these cells ... if they have macular degeneration
"There are ... dozens of retinal degenerative diseases and these diseases are ... caused by the loss of the RPE cells." -Dr. Robert Lanza
Dr. Lanza
(If only 1 percent of the yearly 1.8 million new patients respond as well as Cowboy, that's huge, not tiny. There is NO Treatment available for dry-AMD, And anyone who has it, will want to try RPE Therapy)
"We treated a 75-year-old horse rancher whose vision was 20/400, which is legally blind, and one month[30 Days] after treatment, his vision had improved...[to ]20/40 ... Other patients report similarly dramatic improvements." Lanza added ( Lanza talking about the COMPLETED Phase 1|Phase 2A )
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.